PA
ANRO icon

Perceptive Advisors’s Alto Neuroscience ANRO Stock Holding History

Perceptive Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.2M Buy
2,009,893
+225,500
+13% +$4.18M 0.88% 28
2025
Q4 		$31.8M Buy
1,784,393
+1,629,027
+1,049% +$20.5M 0.57% 46
2025
Q3 		$625K Buy
+155,366
New +$515K 0.02% 88

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Perceptive Advisors's ANRO Position: Q1 2026 in Review

Perceptive Advisors increased its Alto Neuroscience (ANRO) stake by 13% in Q1 2026, buying an estimated $4.18M and bringing the position to 2,009,893 shares worth $45.2M. The position accounts for 0.88% of the portfolio, ranked #28.

Perceptive Advisors first reported a position in ANRO in Q3 2025 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Perceptive Advisors held 2,009,893 shares of Alto Neuroscience worth $45.2M as of Q1 2026.
  • Perceptive Advisors bought 225,500 Alto Neuroscience shares in Q1 2026, an estimated $4.18M.
  • Alto Neuroscience made up 0.88% of Perceptive Advisors's portfolio in Q1 2026, its #28 holding.
  • Perceptive Advisors first reported a position in Alto Neuroscience in Q3 2025 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.